Onconova Therapeutics Announces the Unexpected Passing of Chief Medical Officer Dr. Mark Gelder

April 6, 2023

https://www.globenewswire.com/news-release/2023/04/06/2642977/0/en/Onconova-Therapeutics-Announces-the-Unexpected-Passing-of-Chief-Medical-Officer-Dr-Mark-Gelder.html

NEWTOWN, Pa., April 06, 2023 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (NASDAQ:ONTX), (“Onconova” or “the Company”), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today announced that its Chief Medical Officer (CMO) Mark Gelder, M.D., recently passed away unexpectedly. Michael Saunders, M.D., has been appointed the interim Chief Medical Officer of the Company.

Read more at globenewswire.com

Related news for (ONTX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.